El-Ghanem Mohammad, Malik Ahmed A, Azzam Andre, Yacoub Hussam A, Qureshi Adnan I, Souayah Nizar
Neurological Institute of New Jersey, Rutgers, The State University of New Jersey, Newark, NJ, USA.
Zeenat Qureshi Stroke Institute, St. Cloud, MN, USA.
J Vasc Interv Neurol. 2017 Jun;9(4):54-58.
The proximity of the femoral nerve to the femoral artery renders it vulnerable to injury during transfemoral percutaneous catheterization (TPC) procedures.
To determine the incidence of femoral nerve injury in patients undergoing cardiac catheterization in a nationally representative inpatient database.
We analyzed data released annually from the Nationwide Inpatient Sample. We pooled data from 2002 to 2010 and, using the ICD-9-CM procedure codes, identified patients who underwent TPC. We subsequently identified occurrences of femoral nerve injury in this cohort. Baseline characteristics, comorbid conditions, in-hospital complications, and discharge outcomes-including mortality, mild disability, and moderate-to-severe disability-were compared between patients with femoral neuralgia and those without.
Of the 15,894,201 patients who underwent percutaneous catheterization procedures, 597 (3.8 per 100,000 procedures) developed femoral nerve injury. The incidence of femoral nerve injury was higher in women: 57% versus 39%, < 0.004. Patients with coexisting congestive heart failure or coagulopathy had a non-significant increase in the incidence of femoral nerve injury. There was no in-hospital mortality among patients who developed femoral nerve injury, but the rate of discharge to nursing facilities was higher in this cohort: 17% versus 6%, < 0.001. After adjusting for age, gender, presence of congestive heart failure, and coagulopathy, femoral nerve injury during percutaneous catheterization procedures was independently associated with moderate-to-severe disability at discharge (odds ratio 2.3; 95% confidence interval 1.4-3.8; < 0.001).
Femoral nerve injury is a rare complication of percutaneous catheterization procedures that may increase the likelihood of moderate-to-severe disability at patient's discharge.
股神经与股动脉位置接近,这使得它在经股动脉经皮导管插入术(TPC)过程中容易受到损伤。
在一个具有全国代表性的住院患者数据库中,确定接受心脏导管插入术患者的股神经损伤发生率。
我们分析了每年从全国住院患者样本中发布的数据。我们汇总了2002年至2010年的数据,并使用ICD-9-CM手术编码,确定接受TPC的患者。随后,我们在该队列中确定了股神经损伤的发生情况。比较了股神经痛患者和无股神经痛患者的基线特征、合并症、住院并发症及出院结局,包括死亡率、轻度残疾和中度至重度残疾。
在15894201例接受经皮导管插入术的患者中,597例(每100000例手术中有3.8例)发生了股神经损伤。女性股神经损伤的发生率更高:分别为57%和39%,P<0.004。同时患有充血性心力衰竭或凝血病的患者股神经损伤发生率无显著增加。发生股神经损伤的患者住院期间无死亡,但该队列中出院至护理机构的比例更高:分别为17%和6%,P<0.001。在调整年龄、性别、充血性心力衰竭的存在及凝血病因素后,经皮导管插入术期间的股神经损伤与出院时的中度至重度残疾独立相关(优势比2.3;95%置信区间1.4 - 3.8;P<0.001)。
股神经损伤是经皮导管插入术的一种罕见并发症,可能会增加患者出院时出现中度至重度残疾的可能性。